An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.

by Gunnstein Norheim, Holly Sanders, Jardar W Mellesdal, Idunn Sundfør, Hannah Chan, Carina Brehony, Caroline Vipond, Chris Dold, Rory Care, Muhammad Saleem, Martin C J Maiden, Jeremy P Derrick, Ian Feavers, Andrew J Pollard
Published 2015-01-01